According to The Insight Partners “Liquid Biopsy Market Forecast to 2027”, discusses various factors driving or restraining the market, which will help the future market to grow with promising CAGR. The Liquid Biopsy Market Research Reports offers an extensive collection of reports on different markets covering crucial details. The report studies the competitive environment of the Liquid Biopsy Market is based on company profiles and their efforts on increasing product value and production.
The market is expected to reach US$ 8,123.85 million by 2027 from US$ 3,861.49 million in 2019. It is estimated that the market CAGR accounts for 9.9% during 2020–2027.
The global liquid biopsy market report highlights trends prevailing in the market and factors driving its growth. The liquid biopsy market is attributed to grow due to increasing prevalence of cancer, government and global health organizations initiatives. However, the low sensitivity of liquid biopsy is expected to restraint the global liquid biopsy market growth.
Get Sample Copy of this Report at - https://www.theinsightpartners.com/sample/TIPRE00003996/
Leading Liquid Biopsy Market Players:
- Biocept, Inc
- Bio-Rad Laboratories Inc
- LungLife AI, Inc
- Exosome Diagnostics
- Hoffmann-la Roche ltd
- Exact Sciences Corporation
- Inivata Ltd
- MDxHealth
- Qiagen
- Thermo Fisher Scientific Inc.
Liquid Biopsy Market: Segmental Overview
Product & Services-Based Insights
The global liquid biopsy market, based on product & services, has been segmented into equipment, reagents & kits, and services. The reagents & kits segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR during the forecast period. The growth of reagents & kit segment is attributed to the enhancement of solution to improve staining results and unique antibodies with fluorescent staining markers. There are various reagent & kits available in market for the detection of cancerous cell. For instance, MagMAX cell-free total nucleic acid isolation kit is used to isolate and purify cfRNA and cfDNA from serum, plasma, or urine samples with the help of magnetic bead-based technology.
Reason to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Liquid Biopsy Market
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Liquid Biopsy Market, thereby allowing players to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
Customization of this Report: This report can be customized to meet the client’s requirements. Please connect with our sales team (sales email), who will ensure that you get a report that suits your needs. For more relevant reports visit www.theinsightpartners.com
About The Insight Partners:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defence, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
